Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death is a research paper published in Cell (2024). On theSindex it has a DataRank of 0. It has been cited 97 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA265095
NCI NIH HHS
Grant: P30 CA033572
NCI NIH HHS
Grant: U19 CA264512
NCI NIH HHS
Grant: P01 CA163205
NCI NIH HHS
Grant: R21 CA223400
National Institutes of Health
Grant: CA264512
California Institute for Regenerative Medicine
Grant: DISC2-14190
NCI NIH HHS
Grant: R01 CA247550
National Institutes of Health
Grant: AI129582
NCI NIH HHS
Grant: R01 CA265095
California Institute for Regenerative Medicine
Grant: TRAN1-14716
National Institutes of Health
Grant: CA210087
National Institutes of Health
Grant: NS106170
NIAMS NIH HHS
Grant: R01 AR070116
NINDS NIH HHS
Grant: R01 NS106170
NCI NIH HHS
Grant: R35 CA210087
California Institute for Regenerative Medicine
Grant: TRAN1-14003
NCI NIH HHS
Grant: R01 CA266457
Leukemia and Lymphoma Society
Grant: 1364–19
National Institutes of Health
Grant: CA163205
National Institutes of Health
Grant: CA223400
National Institutes of Health
Grant: CA247550
National Institutes of Health
Grant: CA266457
NIAID NIH HHS
Grant: R01 AI129582
NIAID NIH HHS
Grant: R01 AI172027
MeSH Terms
Keywords